Literature DB >> 2883322

Somatostatin effects in isolated human atrial fibres.

Z Y Hou, C I Lin, T H Chiu, B N Chiang, K K Cheng, L T Ho.   

Abstract

Effects of hypothalamic hormone somatostatin on the action potential and contractile force of 54 human atrial preparations obtained at cardiac surgery were studied with standard microelectrode techniques. In the atrial fibres responding to electrical stimuli with fast response action potentials in 4 mM [K]0 Tyrode solution (maximum rate of phase 0 depolarization greater than 50 V/s), somatostatin (10(-7) to 10(-6) M) reduced slightly the duration of action potential and decreased twitch force dose-dependently. In spontaneously active atrial fibres, somatostatin (10(-7) to 10(-6) M) abolished the action potentials in the preparations with low maximal diastolic potential (MDP, -48 +/- 2.8 mV), but induced only mild suppressive effect in the preparations with high MDP (-70 +/- 2.4 mV). When the fibres were depolarized in 27 mM [K]0 Tyrode solution, somatostatin decreased the maximum rate of depolarization and amplitude of the slow response action potentials induced by electrical stimuli. The delayed afterdepolarizations or triggered action potentials induced by high-frequency electrical drive in the presence of epinephrine were also suppressed by somatostatin. The above findings suggest that somatostatin may suppress the abnormal automaticity and the triggered activity in human atrial fibres through a reduction of cellular calcium.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2883322     DOI: 10.1016/s0022-2828(87)80560-6

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  5 in total

1.  Effects of octreotide on cardiovascular hormones and haemodynamics in conscious dogs.

Authors:  J Donckier; L Stoleru; P Selvais; L Galanti; H Van Mechelen; J M Ketelslegers; A A Charlier
Journal:  J Endocrinol Invest       Date:  1996-02       Impact factor: 4.256

2.  Immunohistochemical and ultrastructural localisation of peptide-containing nerves and myocardial cells in the human atrial appendage.

Authors:  J Wharton; S Gulbenkian; A Merighi; D M Kuhn; R Jahn; K M Taylor; J M Polak
Journal:  Cell Tissue Res       Date:  1988-10       Impact factor: 5.249

3.  Short-term effects of somatostatin analogue (SMS 201-995) on left ventricular function in healthy persons: a scintigraphic study.

Authors:  T Erbas; A Usman; B Erbas; E Varoglu; T Aras; C Bekdik
Journal:  J Endocrinol Invest       Date:  1993-12       Impact factor: 4.256

Review 4.  Electrophysiological features in acromegaly: re-thinking the arrhythmic risk?

Authors:  M Parolin; F Dassie; R Vettor; R P Steeds; P Maffei
Journal:  J Endocrinol Invest       Date:  2020-07-06       Impact factor: 4.256

5.  Suppressive effects of somatostatin in dog Purkinje fibres.

Authors:  C I Lin; M T Su; H N Luk; H L Wu
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.